GB1140766A - Vaccine and its preparation - Google Patents
Vaccine and its preparationInfo
- Publication number
 - GB1140766A GB1140766A GB34791/66A GB3479166A GB1140766A GB 1140766 A GB1140766 A GB 1140766A GB 34791/66 A GB34791/66 A GB 34791/66A GB 3479166 A GB3479166 A GB 3479166A GB 1140766 A GB1140766 A GB 1140766A
 - Authority
 - GB
 - United Kingdom
 - Prior art keywords
 - vaccine
 - chick embryo
 - virus
 - aug
 - virulent
 - Prior art date
 - Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
 - Expired
 
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
 - 210000003837 chick embryo Anatomy 0.000 abstract 4
 - 241000700605 Viruses Species 0.000 abstract 3
 - 229940095293 mumps vaccine Drugs 0.000 abstract 2
 - 102000008100 Human Serum Albumin Human genes 0.000 abstract 1
 - 108091006905 Human Serum Albumin Proteins 0.000 abstract 1
 - ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 abstract 1
 - 229910019142 PO4 Inorganic materials 0.000 abstract 1
 - 229930006000 Sucrose Natural products 0.000 abstract 1
 - CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
 - 239000003708 ampul Substances 0.000 abstract 1
 - 238000004113 cell culture Methods 0.000 abstract 1
 - 239000012568 clinical material Substances 0.000 abstract 1
 - 235000013601 eggs Nutrition 0.000 abstract 1
 - 239000012530 fluid Substances 0.000 abstract 1
 - ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 abstract 1
 - 239000000203 mixture Substances 0.000 abstract 1
 - NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 abstract 1
 - 239000010452 phosphate Substances 0.000 abstract 1
 - 230000001902 propagating effect Effects 0.000 abstract 1
 - 239000008223 sterile water Substances 0.000 abstract 1
 - 239000005720 sucrose Substances 0.000 abstract 1
 - XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
 
Classifications
- 
        
- A—HUMAN NECESSITIES
 - A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
 - A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
 - A61K39/00—Medicinal preparations containing antigens or antibodies
 - A61K39/12—Viral antigens
 - A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
 - A61K39/165—Mumps or measles virus
 
 - 
        
- A—HUMAN NECESSITIES
 - A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
 - A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
 - A61K39/00—Medicinal preparations containing antigens or antibodies
 - A61K39/12—Viral antigens
 
 - 
        
- A—HUMAN NECESSITIES
 - A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
 - A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
 - A61K39/00—Medicinal preparations containing antigens or antibodies
 - A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
 - A61K2039/525—Virus
 - A61K2039/5254—Virus avirulent or attenuated
 
 - 
        
- C—CHEMISTRY; METALLURGY
 - C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
 - C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
 - C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
 - C12N2760/00011—Details
 - C12N2760/18011—Paramyxoviridae
 - C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
 - C12N2760/18734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
 
 
Landscapes
- Health & Medical Sciences (AREA)
 - Life Sciences & Earth Sciences (AREA)
 - Virology (AREA)
 - Pharmacology & Pharmacy (AREA)
 - Animal Behavior & Ethology (AREA)
 - Medicinal Chemistry (AREA)
 - Microbiology (AREA)
 - Mycology (AREA)
 - Chemical & Material Sciences (AREA)
 - Epidemiology (AREA)
 - Immunology (AREA)
 - General Health & Medical Sciences (AREA)
 - Public Health (AREA)
 - Veterinary Medicine (AREA)
 - Communicable Diseases (AREA)
 - Pulmonology (AREA)
 - Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
 - Micro-Organisms Or Cultivation Processes Thereof (AREA)
 
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| US47965365A | 1965-08-13 | 1965-08-13 | 
Publications (1)
| Publication Number | Publication Date | 
|---|---|
| GB1140766A true GB1140766A (en) | 1969-01-22 | 
Family
ID=23904868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| GB34791/66A Expired GB1140766A (en) | 1965-08-13 | 1966-08-03 | Vaccine and its preparation | 
Country Status (14)
| Country | Link | 
|---|---|
| JP (1) | JPS5238089B1 (OSRAM) | 
| BE (1) | BE685270A (OSRAM) | 
| BR (1) | BR6681974D0 (OSRAM) | 
| CH (1) | CH475355A (OSRAM) | 
| CS (1) | CS161688B2 (OSRAM) | 
| CY (1) | CY536A (OSRAM) | 
| DE (1) | DE1617621B1 (OSRAM) | 
| DK (1) | DK116677B (OSRAM) | 
| ES (1) | ES330274A1 (OSRAM) | 
| FI (1) | FI43094B (OSRAM) | 
| FR (2) | FR5807M (OSRAM) | 
| GB (1) | GB1140766A (OSRAM) | 
| IL (1) | IL26244A (OSRAM) | 
| NO (1) | NO122031B (OSRAM) | 
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| FR2076787A5 (en) * | 1970-01-28 | 1971-10-15 | Merieux Inst | Lyophilisation stabiliser - for viruses contg potassium phosphate lactose and albumin | 
- 
        1965
        
- 1965-08-01 IL IL26244A patent/IL26244A/xx unknown
 
 - 
        1966
        
- 1966-07-19 CS CS4877A patent/CS161688B2/cs unknown
 - 1966-08-03 GB GB34791/66A patent/GB1140766A/en not_active Expired
 - 1966-08-04 ES ES0330274A patent/ES330274A1/es not_active Expired
 - 1966-08-08 CH CH1137766A patent/CH475355A/de not_active IP Right Cessation
 - 1966-08-09 BE BE685270D patent/BE685270A/xx not_active IP Right Cessation
 - 1966-08-09 BR BR181974/66A patent/BR6681974D0/pt unknown
 - 1966-08-10 DE DE1966M0070534 patent/DE1617621B1/de active Pending
 - 1966-08-11 FI FI2099/66A patent/FI43094B/fi active
 - 1966-08-12 FR FR72964A patent/FR5807M/fr not_active Expired
 - 1966-08-12 NO NO164282A patent/NO122031B/no unknown
 - 1966-08-12 DK DK414266AA patent/DK116677B/da unknown
 - 1966-08-12 JP JP41052676A patent/JPS5238089B1/ja active Pending
 - 1966-08-12 FR FR73061A patent/FR1509944A/fr not_active Expired
 
 - 
        1970
        
- 1970-04-10 CY CY53670A patent/CY536A/xx unknown
 
 
Also Published As
| Publication number | Publication date | 
|---|---|
| DK116677B (da) | 1970-02-02 | 
| FR1509944A (fr) | 1968-01-19 | 
| IL26244A (en) | 1970-03-22 | 
| CY536A (en) | 1970-04-10 | 
| FI43094B (OSRAM) | 1970-10-01 | 
| NO122031B (OSRAM) | 1971-05-10 | 
| FR5807M (OSRAM) | 1968-02-19 | 
| JPS5238089B1 (OSRAM) | 1977-09-27 | 
| CS161688B2 (OSRAM) | 1975-06-10 | 
| BR6681974D0 (pt) | 1973-12-26 | 
| DE1617621B1 (de) | 1971-03-04 | 
| BE685270A (OSRAM) | 1967-02-09 | 
| ES330274A1 (es) | 1967-06-16 | 
| CH475355A (de) | 1969-07-15 | 
Similar Documents
| Publication | Publication Date | Title | 
|---|---|---|
| US4622222A (en) | Process for the preparation of a lyophilized vaccine against duck virus hepatitis | |
| US4224412A (en) | Living virus culture vaccine against canine distemper and method of preparing same | |
| GB1177635A (en) | Cell Stains. | |
| ES373631A1 (es) | Procedimiento para la obtencion de una vacuna activa contrala enfermedad de maret. | |
| US4571386A (en) | Feline infectious peritonitis vaccine | |
| HU194496B (en) | Process for preparing a living vaccine against marek disease | |
| GB1140766A (en) | Vaccine and its preparation | |
| Larsh et al. | Conversion and maintenance of Histoplasma capsulatum in tissue culture | |
| KR20000069501A (ko) | 뉴우캐슬병에 대한 난내 백신화 | |
| US3548055A (en) | Infectious bursal disease vaccine | |
| Eddy et al. | Persistent infection of human carcinoma and primary chick embryo cell cultures with simian virus 40 | |
| CA2178553A1 (en) | Marek's disease vaccine | |
| US4554158A (en) | Modified live sendai virus vaccine for administering through an aerosol and method of producing the same | |
| Mancini et al. | Cultivation of avian encephalomyelitis virus in vitro. 2. In chick embryo fibroblastic cell culture | |
| US3401084A (en) | Rubella vaccine and its preparation | |
| Goodpasture et al. | The Protective Action of Rabbit Serum for Vaccinia Virus at High Temperatures | |
| Zinsser et al. | Further Studies on Typhus Fever: On Homologous Active Immunization against the European Strain of Typhus Fever | |
| Faulkner et al. | Propagation of a strain of rabbit fibroma virus in tissue-culture | |
| Freund | Retardation of tuberculous infection in guinea pigs vaccinated with killed tubercle bacilli as shown by cultural method | |
| Graham et al. | The toxicity of P32 for normal and influenza virus infected embryos | |
| YU46029B (sh) | Postopek za pripravo živega cepiva proti mumpsu | |
| Hetherington | Frozen-Dried Serum as a Medium Constituent for Tissue Cultures. | |
| GB1152645A (en) | Rubella Vaccine | |
| Black | Wound-tumor | |
| GB1152626A (en) | Rubella Vaccine |